Study to Assess the Efficacy of EMC-CAP-2025A on Age-Related Skin Parameters in Healthy Individuals (NCT07493850) | Clinical Trial Compass
Active — Not RecruitingPhase 2
Study to Assess the Efficacy of EMC-CAP-2025A on Age-Related Skin Parameters in Healthy Individuals
India60 participantsStarted 2026-02-27
Plain-language summary
The goal of this clinical study is to evaluate the efficacy and tolerability of EMC-CAP-2025A, an eggshell membrane-based dietary supplement, on age-related skin parameters in healthy adults.
The main questions this study aims to answer are:
* Does daily supplementation with EMC-CAP-2025A improve facial wrinkles compared to placebo?
* Does EMC-CAP-2025A improve skin hydration, firmness, elasticity, texture, and overall skin quality?
* Is EMC-CAP-2025A well tolerated when taken daily for 60 days?
Researchers will compare EMC-CAP-2025A to a placebo to assess its effects on multiple skin parameters using objective instrumental assessments and participant self-evaluations.
Participants will:
* Be randomly assigned to receive either EMC-CAP-2025A or a placebo
* Take one capsule orally once daily for 60 days
* Attend scheduled study visits at baseline, Day 30, and Day 60 for instrumental skin assessments and safety evaluations
* Complete self-assessment questionnaires related to skin quality and product tolerability
Who can participate
Age range30 Years – 55 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Individuals who are willing to understand and sign a written informed consent form prior to the study.
✓. Healthy male and female individuals aged between 30 to 55 years (both values included).
✓. Individuals showing symptoms of aging, with mild to moderate wrinkles in crow's feet area based on PI discretion.
✓. Individuals with any one of the following skin conditions along with mild to moderate wrinkles:
✓. Individuals willing to maintain stable dietary patterns and maintain adequate hydration every day throughout the study
Exclusion criteria
✕. Individuals having an allergy to any of the components of the IP.
What they're measuring
1
To assess the effect of Investigational product at Day 60 in comparison to baseline and placebo on Wrinkles in the nasolabial and lateral canthal region near the eyes (crow's feet)
. Use of another investigational product within 90 days prior to the screening visit.
✕. Individuals with any dermatologic disorders or skin conditions that could interfere with the evaluation of proprietary supplement's effects.
✕. Individuals having an underlying disease or surgical or medical condition that could put them at risk in the opinion of Principal Investigator, including anyuncontrolled chronic or serious disease that would prevent participation in the study, such as cancer, AIDS, diabetes, obesity, renal impairment, psychiatricdisorder, compromised immunity, etc.
✕. Individuals having a history of self-reported allergies to cosmetic and/or sunscreen products.
✕. Individuals who have used or are unwilling to abstain from using any topical or systemic skin-treatment products or dietary supplements with claims toimprove skin hydration, firmness, anti-aging, anti-wrinkle, skin lightening, or dyschromia correction - including those containing alpha/beta/poly-hydroxyacids, salicylic acid, vitamin C, collagen, hyaluronic acid, soy, CoQ-10, chondroitin sulfate, hydroquinone, corticosteroids, tretinoin, retinoids, or anycombination thereof - within 1 month prior to screening or during the study period.
✕. Individuals currently using oral or topical health foods, supplements, pharmaceuticals, or cosmetics that claim whitening or skin-texture improvementeffects such as but not limited to glutathione, cysteine, placenta-based extracts, Vitamins C/E/A (retinol), astaxanthin, lycopene, etc., and who cannotrefrain from using them during the study period.
✕. Individuals who have undergone any facial cosmetic or aesthetic procedures, including beauty injections, deep or superficial-to-mid chemical peels,dermabrasion, laser resurfacing, Thermage, tanning, cosmetic surgery, or any equivalent high-energy or anti-aging facial treatments, within 3 months priorto the screening visit.